VERAXA Biotech advances VXA-222 bispecific ADC program with OmniAb
Go back to VERAXA Biotech advances VXA-222 bispecific ADC program with OmniAb| (NASDAQ: OABI) | Delayed: 4.92 +0.05 (1.03%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.87 | 52 Week High | $ | |||
| Open | $4.83 | 52 Week Low | $ | |||
| Day High | $5.02 | P/E | N/A | |||
| Day Low | $4.64 | EPS | $ | |||
| Volume | 1,215,145 | |||||
| (NASDAQ: VRXA) | Delayed: 1.13 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.13 | 52 Week High | $ | |||
| Open | $1.13 | 52 Week Low | $ | |||
| Day High | $1.16 | P/E | N/A | |||
| Day Low | $1.12 | EPS | $ | |||
| Volume | 154,077 | |||||



